Outcomes of intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 90 years or older (Q24646395)

7

object named as

Eelco F M Wijdicks

0 references

author name string

Farrah J Mateen

1

0 references

Majeed Nasser

2

0 references

Byron R Spencer

3

0 references

William D Freeman

4

0 references

Ashfaq Shuaib

Thrombolysis for acute ischaemic stroke

5

0 references

language of work or name

English

0 references

publication date

April 2009

0 references

published in

Mayo Clin Proc

0 references

volume

84

0 references

issue

4

0 references

page(s)

334-8

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2665978

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2665978

Tissue plasminogen activator for acute ischemic stroke

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2665978

Acute stroke management in the elderly

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2665978

Intravenous thrombolysis in stroke patients of > or = 80 versus < 80 years of age--a systematic review across cohort studies.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2665978

Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2665978

Thrombolysis for acute stroke with special emphasis on the very old: experience from a single Dutch centre

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2665978

Intravenous rt-PA for acute stroke: comparing its effectiveness in younger and older patients

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2665978

Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke? - The Calgary experience

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2665978

Stroke in the very old : clinical presentation and determinants of 3-month functional outcome: A European perspective. European BIOMED Study of Stroke Care Group.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2665978

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2665978

Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis

19 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2665978

Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (> or =80 years) stroke patients.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2665978

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2665978

Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke

28 November 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2960542-9

The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2960542-9

Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older : the tPA stroke survey experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2960542-9

Strokes in the elderly - higher acute and 3-month mortality - an explanation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2960542-9

Short- and long-term prognosis for very old stroke patients. The Copenhagen Stroke Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2960542-9

Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2960542-9

Intravenous TPA for very old stroke patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2960542-9

Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2960542-9